Atherogenic Index of Plasma (AIP) a Tool to Assess Changes in Cardiovascular Disease Risk Post Laparoscopic Sleeve Gastrectomy

Table 1

Clinical characteristics of study participants subjects at baseline.

Variable	Morbid obese		value	Normal weight		value
	With T2D	Without T2D		With T2D	Without T2D
Age (year)						0.008
Weight (kg)
Height (cm)
BMI (kg/m^2)
Body fat (%)
Abdominal circumference (cm)
Waist/hip ratio						0.01
SBP (mmHg)
DBP (mmHg)
Vascular age (year)			0.0001			0.0001
TC (mM)
TG (mM)	1.54 (1.07-2.02)	0.92 (0.71-1.65)	0.01	1.29 (0.91-1.73)	0.66(0.45-0.82)	0.001
LDL (mM)
HDL (mM)			0.003			0.0008
VLDL (mM)			0.025			0.056
oxLDL (mg/mL)			0.007
AIP (log TG/HDL)			0.0001			0.0006
hsCRP (mg/dl)
Insulin (pg/mL)			0.0004			0.03
c-peptide (pg/mL)			0.01
FPG (mM)			0.0001			0.0001
A1c (%)			0.0001			0.0001
ALT (IU/L)	51 (39.5-67)	43 (35-56)		42 (38-54)	34 (32-39)	0.005
AST (IU/L)	25 (19.5-36)	20 (16-30)		18 (16-22)	19 (16.75-20.5)
Sex (women/men)	13 : 4	16 : 7		7 : 13	8 : 7

Baseline data are presented as , or median with interquartile. Based on the normality test, nonparametric comparison (Mann–Whitney test) or unpaired -test (two-tailed) was applied to test significance between diabetic and nondiabetic subjects in both groups, value ≤0.05 was considered significant (), and value <0.01 indicates highly significant values (). SBP, DBP: Systolic and diastolic blood pressure; TC: total cholesterol; TG: triglycerides;ALT: alanine aminotransferase; AST: aspartate aminotransferase; hsCRP: high-sensitivity c-reactive protein; FPG: fasting plasma glucose; A1c: hemoglobin A1c.